Bell Bank raised its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 4.4% during the first quarter, Holdings Channel reports. The firm owned 2,392 shares of the healthcare conglomerate’s stock after buying an additional 100 shares during the period. Bell Bank’s holdings in UnitedHealth Group were worth $392,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of UNH. Dodge & Cox acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $1,658,560,000. Norges Bank acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $1,530,177,000. Viking Global Investors LP acquired a new stake in UnitedHealth Group during the fourth quarter worth approximately $354,206,000. Swiss National Bank boosted its stake in UnitedHealth Group by 25.8% in the first quarter. Swiss National Bank now owns 3,719,488 shares of the healthcare conglomerate’s stock worth $610,033,000 after buying an additional 763,161 shares during the period. Finally, Teachers Advisors LLC boosted its stake in UnitedHealth Group by 56.8% in the fourth quarter. Teachers Advisors LLC now owns 1,929,490 shares of the healthcare conglomerate’s stock worth $308,796,000 after buying an additional 698,955 shares during the period. Institutional investors and hedge funds own 86.21% of the company’s stock.

Shares of UnitedHealth Group Inc (UNH) opened at 186.35 on Tuesday. The stock has a market cap of $179.58 billion, a P/E ratio of 23.85 and a beta of 0.63. UnitedHealth Group Inc has a 52-week low of $132.39 and a 52-week high of $188.66. The firm has a 50-day moving average price of $178.98 and a 200-day moving average price of $168.66.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, beating analysts’ consensus estimates of $2.17 by $0.20. The firm had revenue of $48.72 billion for the quarter, compared to analysts’ expectations of $48.21 billion. UnitedHealth Group had a return on equity of 21.73% and a net margin of 4.50%. UnitedHealth Group’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.81 EPS. On average, analysts anticipate that UnitedHealth Group Inc will post $9.80 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 27th. Stockholders of record on Monday, June 19th were issued a dividend of $0.75 per share. This is a boost from UnitedHealth Group’s previous quarterly dividend of $0.63. The ex-dividend date of this dividend was Thursday, June 15th. This represents a $3.00 annualized dividend and a dividend yield of 1.61%. UnitedHealth Group’s dividend payout ratio (DPR) is 37.36%.

COPYRIGHT VIOLATION WARNING: “Bell Bank Has $392,000 Stake in UnitedHealth Group Inc (UNH)” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another domain, it was copied illegally and republished in violation of international trademark and copyright legislation. The legal version of this story can be viewed at https://www.dailypolitical.com/2017/07/18/bell-bank-has-392000-stake-in-unitedhealth-group-inc-unh.html.

A number of analysts have recently commented on UNH shares. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday, May 19th. Deutsche Bank AG started coverage on UnitedHealth Group in a research report on Wednesday, April 5th. They issued a “buy” rating and a $183.00 price objective for the company. Vetr upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $179.00 price objective for the company in a research report on Wednesday, April 5th. Cantor Fitzgerald restated an “overweight” rating and issued a $200.00 price objective on shares of UnitedHealth Group in a research report on Thursday, April 6th. Finally, Mizuho boosted their price objective on UnitedHealth Group from $178.00 to $200.00 and gave the company a “buy” rating in a research report on Tuesday, April 18th. One equities research analyst has rated the stock with a hold rating, twenty-five have assigned a buy rating and one has assigned a strong buy rating to the stock. UnitedHealth Group has a consensus rating of “Buy” and a consensus price target of $188.10.

In other news, Director Gail R. Wilensky sold 5,540 shares of the firm’s stock in a transaction on Friday, June 2nd. The stock was sold at an average price of $178.74, for a total transaction of $990,219.60. Following the sale, the director now owns 60,516 shares in the company, valued at $10,816,629.84. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP D Ellen Wilson sold 14,000 shares of the firm’s stock in a transaction on Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total value of $2,387,560.00. Following the sale, the executive vice president now owns 31,993 shares in the company, valued at approximately $5,456,086.22. The disclosure for this sale can be found here. Insiders have sold 30,378 shares of company stock worth $5,285,052 in the last 90 days. Insiders own 0.89% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc and related companies with MarketBeat.com's FREE daily email newsletter.